Investigators at the Mayo Clinic, Rochester, MN; George Washington University, and Children’s National Brain Tumor Institute, Washington, DC review the molecular pathways implicated in pediatric brain tumors, biologic agents that target these pathways, and current clinical trials of these novel therapies
Brain tumors are the leading cause of cancer-related death in children. Genomic studies have provide...
UnrestrictedBrain tumors represent the most common solid tumor in children and are the leading cause...
International audienceBackground: The role of tumor molecular profiling in directing targeted therap...
Pediatric brain tumors are the most common solid malignancies in children. Advances in the treatment...
Pediatric neurological tumors are a heterogeneous group of cancers, many of which carry a poor progn...
Brain tumors are the most common solid tumors in children and are associated with high mortality. Th...
Diagnosis and treatment of paediatric brain tumours has shown limited progress over the last half ce...
This thesis assesses molecular underpinnings of responses to promising targeted agents for pediatric...
Current methods of diagnosis and treatment of medulloblastoma, and the influence of new biological a...
Approximately five out of 100,000 children from 0 to 19 years old are diagnosed with a brain tumor. ...
Pediatric malignant brain tumors represent the most frequent cause of cancer-related deaths in child...
The results of chemotherapy in the treatment of selected brain tumors in children are reviewed by th...
The overall survival of pediatric gliomas varies over a wide spectrum depending on the tumor grade. ...
Neuroblastoma is the most common extra-cranial solid tumor encountered in childhood and accounts for...
Purpose of Review Over the last years, our understanding of the molecular biology of pediatric br...
Brain tumors are the leading cause of cancer-related death in children. Genomic studies have provide...
UnrestrictedBrain tumors represent the most common solid tumor in children and are the leading cause...
International audienceBackground: The role of tumor molecular profiling in directing targeted therap...
Pediatric brain tumors are the most common solid malignancies in children. Advances in the treatment...
Pediatric neurological tumors are a heterogeneous group of cancers, many of which carry a poor progn...
Brain tumors are the most common solid tumors in children and are associated with high mortality. Th...
Diagnosis and treatment of paediatric brain tumours has shown limited progress over the last half ce...
This thesis assesses molecular underpinnings of responses to promising targeted agents for pediatric...
Current methods of diagnosis and treatment of medulloblastoma, and the influence of new biological a...
Approximately five out of 100,000 children from 0 to 19 years old are diagnosed with a brain tumor. ...
Pediatric malignant brain tumors represent the most frequent cause of cancer-related deaths in child...
The results of chemotherapy in the treatment of selected brain tumors in children are reviewed by th...
The overall survival of pediatric gliomas varies over a wide spectrum depending on the tumor grade. ...
Neuroblastoma is the most common extra-cranial solid tumor encountered in childhood and accounts for...
Purpose of Review Over the last years, our understanding of the molecular biology of pediatric br...
Brain tumors are the leading cause of cancer-related death in children. Genomic studies have provide...
UnrestrictedBrain tumors represent the most common solid tumor in children and are the leading cause...
International audienceBackground: The role of tumor molecular profiling in directing targeted therap...
DOI
Add to ORKG